Advisory Services Network, LLC Veracyte, Inc. Transaction History

Advisory Services Network, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$19.72 - $28.68 $3,549 - $5,162	180 New	180 $4,000
Q1 2023 May 17, 2023	BUY	$20.58 - $27.89 $782 - $1,059	38 Added 9.38%	443 $9,000
Q4 2022 Feb 13, 2023	BUY	$15.31 - $29.94 $6,200 - $12,125	405 New	405 $9,000
Q2 2022 Aug 02, 2022	SELL	$15.45 - $29.52 $379,977 - $726,014	-24,594 Closed	0 $0
Q1 2022 May 23, 2022	BUY	$21.94 - $42.51 $42,278 - $81,916	1,927 Added 8.5%	24,594 $678,000
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $72,504 - $108,064	2,009 Added 9.73%	22,667 $934,000
Q3 2021 Nov 05, 2021	SELL	$35.62 - $52.97 $113,200 - $168,338	-3,178 Reduced 13.33%	20,658 $960,000
Q2 2021 Aug 12, 2021	SELL	$32.94 - $56.62 $89,036 - $153,043	-2,703 Reduced 10.19%	23,836 $953,000
Q1 2021 May 24, 2021	BUY	$44.47 - $81.38 $633,786 - $1.16 Million	14,252 Added 115.99%	26,539 $1.43 Million
Q4 2020 Feb 09, 2021	BUY	$32.49 - $61.88 $392,706 - $747,943	12,087 Added 6043.5%	12,287 $601,000
Q3 2020 Nov 16, 2020	BUY	$26.73 - $35.67 $5,346 - $7,134	200 New	200 $6,000
Q1 2020 May 15, 2020	SELL	$16.13 - $30.17 $1,564 - $2,926	-97 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$20.78 - $29.99 $2,015 - $2,909	97 New	97 $3,000

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.